AJMC November 21, 2024
Maggie L. Shaw

Key Takeaways

  • Immunotherapy in NSCLC faces challenges like high costs, limited access, and the need for optimized dosing and understanding of drug mechanisms.
  • Precision medicine in breast cancer is evolving with new HER2 concepts and targeted treatments, emphasizing the need for better biomarkers.
  • Sarcoma care benefits from advancements in predictive biomarkers, though challenges remain due to the rarity and heterogeneity of the disease.
  • Pharmacy decision-making in oncology is crucial for optimizing treatment outcomes and managing healthcare costs, with pharmacists playing a key role.
  • Equitable access to advanced cancer treatments and improved healthcare efficiency are essential for achieving value-based oncology care.

Coverage from the IVBM Regional event in Boston, Massachusetts.

The first regional event of Institute for Value-Based Medicine,®...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Equity/SDOH, Healthcare System, Patient / Consumer, Provider, Value Based
Related Articles:
How Alignment with Sound Physicians’ ACO Improved Patient Care and Outcomes
Mastering the shift to value-based care: 3 strategies for organization-wide success
CMS ending VBID model due to high costs
CMS ends value-based Medicare Advantage model: 5 things to know
CMS taps 4 states for behavioral innovation model: 5 things to know

Share This Article